Loading…
Transforming hepatitis B care through innovation, prevention, and long-term disease control.
Office bearers
Prof. Sanjaya Satapathy
Chair
MD · Liver Transplant
Why this SIG, right now
The management of hepatitis B is entering a new era—defined by advances in therapy, global health initiatives, and the pursuit of cure.
Three key forces define this moment:
HBV remains a leading cause of cirrhosis and hepatocellular carcinoma worldwide.
First-line agents such as:
Join Hepatitis B Virus (HBV) Special Interest Group to read and participate in the discussion board.